Bering Capital

Transforming Healthcare

Developing the early DNA of business through trust and culture

Navigating innovative business with early strategic insights

Reliable expertise in a volatile world

Creating a new world with fundamentally strong companies

Passionate about the future, visionary in how to build it

We believe in the primacy of great markets and great people all aligned with one mission

About Us

Seasoned partners in navigating varied stages of growth

People

We help build great companies with inspiration and support

Companies

Latest News

View All

01.05.2026

Coherus Publication in Molecular Cancer Therapeutics Highlights Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)

12.08.2025

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma

12.03.2024

Coherus sells its last biosimilar Udenyca to Intas for up to $558M as company homes in on novel cancer meds

06.27.2024

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)